Pergolide in the management of restless legs syndrome: An extended study

Sleep

Volumn 20, Issue 10, 1997, Pages 878-882

  Silber, Michael H ^a   Shepard Jr , John W ^a   Wisbey, Joyce A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Pergolide; Restless legs syndrome; Sleep disorders

Indexed keywords

BENZODIAZEPINE; CARBIDOPA PLUS LEVODOPA; CLONAZEPAM; CODEINE; DEXTROPROPOXYPHENE; DIAZEPAM; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; FLURAZEPAM; LEVODOPA; METHADONE; OPIATE AGONIST; OXAZEPAM; OXYCODONE; PERGOLIDE; TRIAZOLAM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOPAMINERGIC SYSTEM; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; HUMAN; INSOMNIA; MALE; NAUSEA; PARKINSON DISEASE; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SLEEP DISORDER; TREATMENT OUTCOME; VERTIGO;

EID: 0030781370     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/20.10.878     Document Type: Article

References (28)

1. Walters AS and The International Restless Legs Syndrome Study Group. Toward a better definition of the restless legs syndrome. Mov Disord 1995;10:634-42.
2. Lavigne GJ, Montplaisir JY. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 1995;17:739-43.
3. Montagna P, Sassoli de Bianchi L, Zucconi M, Cirignotta F, Lugaresi E. Clonazepam and vibration in restless legs syndrome. Acta Neurol Scand 1984;69:428-30.
4. Walters AS, Wagner ML, Hening WA, et al. Succesful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep 1993;16:327-32.
5. Brodeur C, Montplaisir J, Godbout R, Marinier R. Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study. Neurology 1988; 38:1845-8.
6. Trenkwalder C, Stiasny K, Pollmacher Th, et al. L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind crossover trial. Sleep 1995;18:681-8.
7. Walters AS, Hening WA, Kavey N, Chockroverty S, Gidro-Frank S. A double-blimd randomized crossover trial of bromocriptine and placebo in restless legs syndrome. Ann Neurol 1988;24:455-8.
8. Allen RP, Earley CJ. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 1996;19:205-13.
9. Langtry HD, Clissold SP. Pergolide: a review of its pharmacological properties and therapeutic potentials in Parkinson's disease. Drugs 1990;39:491-506.
10. Goetz CJ, Diederich NJ. Dopaminergic agonists in the treatment of Parkinson's disease. Neurol Clin 1992;10:527-40.
11. Lin S-C, Kaplan J, Burger C, Fredrickson P. The effect of pergolide on the treatment of resistant restless legs syndrome. Sleep Res 1995;24:277.
12. Diagnostic Classification Steering Committee, Thorpy MJ, Chairman. International classification of sleep disorders: diagnostic and coding manual. Rochester, MN: American Sleep Disorders Association, 1990:65-71.
13. Coleman RM. Periodic movements in sleep (nocturnal myoclonus) and restless legs syndrome. In: Guilleminault C, ed. Sleeping and waking disorders: indications and techniques. Palo Alto, CA: Addison-Wesley, 1982:265-95.
14. Earley CJ, Allen RP Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic limb movements in sleep in a consecutive series of patients. Sleep 1996; 19:801-10.
15. Becker PM, Jamieson AO, Brown WD. Dopaminergic agents in restless legs syndrome and periodic limb movements of sleep: response and complications of extended treatment in 49 cases. Sleep 1993;16:713-6.
16. Von Scheele C, Kempi V. Long-term effect of dopaminergic drugs in restless legs: a 2-year follow-up. Arch Neurol 1990;47: 1223-4.
17. Montplaisir J, Lapierre O, Warnes H, Pelletier G. The treatment of restless legs syndrome with or without periodic limb movements in sleep. Sleep 1992;15:381-95.
18. Kaplan PW, Allen RP, Buchholz DW, Walters JK. A double-blind, placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa/levodopa and propoxyphene. Sleep 1993;16:717-23.
19. Guilleminault C, Catel M, Philip P. Dopaminergic treatment of restless legs and rebound phenomenon. Neurology 1993;43:445.
20. Seeman P, Van Tol HHM. Dopamine receptor pharmacology. Curr Opin Neurol Neurosurg 1993;6:602-8.
21. Ahlskog E, Muenter MD. Treatment of Parkinson's disease with pergolide: a double-blind study. Mayo Clin Proc 1988;63:969-78.
22. Olanow CW, Alberts MJ. Double-blind controlled study of pergolide mesylate in the treatment of Parkinson's dfisease. Clin Neuropharmacol 1987;10:178-85.
23. Olanow CW, Fahn S, Muenter M, et al. A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet® in Parkinson's disease. Mov Dis 1994;9:40-7.
24. Mizuno Y, Kondo T, Narabayashi H. Pergolide in the treatment of Parkinson 's disease. Neurology 1995;45 (Suppl 3):S13-21.
25. Pezzoli G, Martignoni E, Pacchetti C, et al. A crossover, controlled study comparing pergolide with bromocriptine as an adjunct to the levodopa for the treatment of Parkinson's disease. Neurology 1995;45 (Suppl 3):S22-7.
26. Factor SA, Sanchez-Ramos JR, Weiner WJ. Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapy. J Neurol Neurosurg Psychiatry 1988;51:529-33.
27. Blackard WG. Edema - an infrequently recognized complication of bromocriptine and other ergot dopaminergic drugs. Am J Med 1993:94:445.
28. Trenkwalder C, Winkelmann J, Stiasny K, Wetter TC, Oertel WH. Treatment of the restless legs syndrome with pergolide. Neurology 1997;48:A360.